Kaneka (TSE:4118) just announced the launch of its i-ED COIL brain aneurysm treatment device in Europe after receiving regulatory approval, alongside plans to boost its dividend payout. Both moves ...

PASADENA, Texas, May 19, 2025 /PRNewswire/ -- Kaneka North America LLC Nutrients Division ("Kaneka Nutrients") has initiated comprehensive efforts to identify and expose misleading claims about ...

TOKYO--(BUSINESS WIRE)--Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Kazuhiko Fujii) (TOKYO:4118) has obtained “Halal Certificate (Certification Number: 355-TSRI/24)” for its ...

IRVINE, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Toro Neurovascular, a company pioneering advanced catheter technologies for neurovascular intervention, today announced an exclusive distribution ...

Kaneka Eurogentec, a custom service and FDA inspected Contract Development and Manufacturing Organization (CDMO) received GMP accreditation by the Belgian ministry of health for the GMP manufacturing ...

Sydney and Kuala Lumpur events unite world-leading experts as Mitochondrial Health gains recognition as a defining force in healthy ageing, and healthspanResearchers and clinicians identify ...

Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter An update from Kaneka ( (JP:4118)) is now available. Kaneka Corporation has introduced ...

Ubiquinol-powered Mitochondrial Health moves front and centre across food, nutraceutical and beverage formulations worldwide as consumer demand accelerates for cellular health solutions A first of its ...

The Nature Index tracks primary research articles from 178 applied, health, natural and social sciences journals, across many different publishers, chosen by an independent group of researchers. The ...

SYDNEY, Dec. 6, 2024 /PRNewswire/ -- Kaneka Ubiquinol™ has been awarded the coveted Raw Material Supplier of the Year Award 2024 at the Complementary Medicines Australia (CMA) Awards, held in Sydney ...

Kaneka ( (JP:4118)) just unveiled an announcement. Kaneka Corporation reported progress on its ongoing share repurchase program authorized by its board in May 2025, detailing that it bought back ...

P/E Ratio (w/o extraordinary items) 9.50 ...